Valuation : Prenetics Global Limited

Market Cap 438M 378M 356M 324M 606M 41.36B 611M 4.21B 1.64B 21.15B 1.64B 1.61B 69.47B P/E 2026 *
-7.75x
P/E 2027 * -21.6x
Enterprise Value 438M 378M 356M 324M 606M 41.36B 611M 4.21B 1.64B 21.15B 1.64B 1.61B 69.47B EV / Sales 2026 *
1.96x
EV / Sales 2027 * 1.09x
Free-Float
85.5%
Yield 2026 *
-
Yield 2027 * -
1 day+0.93%
1 week+1.05%
Current month-0.76%
1 month+39.75%
3 months+24.23%
6 months+64.46%
Current year+65.40%
1 week 25.01
Extreme 25.01
27.24
1 month 17.4
Extreme 17.4
27.24
Current year 14
Extreme 14
27.24
1 year 7.9
Extreme 7.9
27.24
3 years 2.85
Extreme 2.85
27.24
5 years 2.85
Extreme 2.85
131.25
10 years 2.85
Extreme 2.85
131.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 52 2013-12-31
Chief Executive Officer 47 2013-12-31
Director of Finance/CFO 41 2017-12-31
Director TitleAgeSince
Chairman 47 2013-12-31
Director/Board Member 38 -
Director/Board Member - 2026-02-15
Date Insider Type Main position Quantity % Market Cap. Importance
8/25/26 Buy

CFO of IM8 (US) LLC

5,100 0.0328%
8/24/26 Buy

Chief Executive Officer

17,181 0.1104%
8/21/26 Exercice

Chief Financial Officer

615,395 3.9543%
Change 5-day change 1-year change 3-year change Capi.($)
+0.93%+1.05%+219.63%+220.71% 436M
+1.41%-3.18%-15.97%+7.41% 188B
+0.15%+0.17%-1.23%+12.24% 118B
+1.63%+2.61%+14.08%+92.25% 63.16B
-1.23%-1.41%+23.53%+46.72% 52.01B
+0.21%-1.41%-0.33%-32.66% 50.97B
-0.50%+0.82%+20.71%-11.98% 34.02B
+3.39%+4.97% - - 30.8B
+1.18%-2.08%+40.57%-15.96% 23.83B
-0.18%-3.69%-6.33%+13.51% 23.45B
Average +0.66%+0.66%+32.74%+36.92% 58.5B
Weighted average by Cap. +0.67%-1.71%+1.01%+16.34%

Financials

2026 *2027 *
Net sales 224M 193M 182M 166M 310M 21.13B 312M 2.15B 835M 10.8B 840M 822M 35.49B 400M 345M 325M 296M 554M 37.8B 558M 3.85B 1.49B 19.32B 1.5B 1.47B 63.48B
Net income -64.13M -55.33M -52.12M -47.49M -88.76M -6.06B -89.43M -617M -239M -3.1B -241M -236M -10.17B -21.51M -18.55M -17.48M -15.93M -29.77M -2.03B -29.99M -207M -80.31M -1.04B -80.76M -79M -3.41B
Net Debt - -
Logo Prenetics Global Limited
Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Employees
98
Date Price Change Volume
26-09-02 US$26.05 +0.93% 336,484
26-09-01 US$25.81 -1.68% 181,542
26-08-31 US$26.25 +1.90% 196,919
26-08-28 US$25.76 -1.87% 273,752
26-08-27 US$26.25 +1.82% 952,681
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
25.95USD
Average target price
35.17USD
Spread / Average Target
+35.52%

Quarterly revenue - Rate of surprise